Yuhong Jiang, PhD

School of Life Science and Engineering, Southwest Jiaotong University

EDUCATION AND ACADEMIC EXPERIENCES

2007-2011          Bachelor of Science      West china school of pharmacy, Sichuan University  

2011-2014          Master of Science          West china school of pharmacy, Sichuan University

2014-2018          Doctor of Philosophy    Institution for Molecular Bioscience, University of Queensland, Australia

                                                                    Academic visiting the University of California, San Francisco, USA

                                                                    Ambassador for The Australian Research Council Centre of Excellence in Advanced Molecular Imaging

2018-2021      Lecturer                           School of Life Science and Engineering, Southwest Jiaotong University

2021-present   Associate Professor      School of Life Science and Engineering, Southwest Jiaotong University

Prof. Jiang has published over 30 SCI-indexed papers as first author or corresponding author in international journals including ACS Nano, Acta Pharmaceutica Sinica B, Biomaterials, Journal of Controlled Release, British Journal of Pharmacology, Biomaterials, and ACS Chemical Biology. They have served as principal investigator for projects funded by the National Natural Science Foundation of China (Young Scientists Fund), the Department of Science and Technology of Sichuan Province, the Department of Human Resources and Social Security of Sichuan Province (Scientific and Technological Activities for Returned Overseas Chinese Scholars), the Chengdu Science and Technology Program (Technological Innovation and R&D Program), the Fundamental Research Funds for the Central Universities (Scientific and Technological Innovation Program), and the Basic Research and Medical-Engineering Interdisciplinary Cultivation Special Fund. She has been invited to present oral presentations or poster sessions at international conferences including the American Association of Pharmaceutical Scientists Asian Conference, the Centre for Advanced Molecular Imaging Conference, and the Pharmaceutica Conference.

RESEARCH INTERESTS 

Molecular Pharmaceutics--Nanomedicine, drug delivery system 

Molecular Pharmacology--Mechanism of immune/tumour-targeted drugs

VACANCIES

Undergraduate Students. Students wishing to do SRTP or 4th-year graduation projects are invited to contact and apply.

Potential Master Students. Students majoring in Pharmaceutics, Pharmacology and Biology are invited to apply and are competitively chosen based on their research CVs, motivation and academic ethic.

Lab Visiting are welcome at any time.

CONTACT 

Email: yuh.jiang@foxmail.com, yuhong.jiang@swjtu.edu.cn

Address: No. 111, North 1st Section, 2nd Ring Road Chengdu, Sichuan, China

SELECTED PUBLICATIONS：

• Yue Wu, Xiaoyu Liang, Canquan Mao, Yuhong Jiang*. The distinct properties of polysaccharide nanoparticles tune immune responses against mRNA antigen via stimulator of interferon genes-mediated autophagy and inflammasome. ACS Nano. 2023; 17: 21782−21798 (IF= 17.1)

• Xiujuan Fu, Jianbin Li, Yue Wu, Canquan Mao, Yuhong Jiang*. PAR2 deficiency tunes inflammatory microenvironment to magnify STING signalling for mitigating cancer metastasis via anionic CRISPR/Cas9 nanoparticles. J. Control. Release. 2023; 363:733-746 (IF= 10.8)

• Xin Zhuo, Yue Wu, Xiujuan Fu, Jianbin Li, Yuxin Xiang, Xiaoyu Liang, Canquan Mao, Yuhong Jiang*. Genome editing of PAR2 through targeted delivery of CRISPR-Cas9 system for alleviating acute lung inflammation via ERK/NLRP3/IL-1β and NO/iNOS signalling. Acta Pharm. Sin. B. 2024; 14(3): 1441-1456 (IF= 14.5)

• Yuhong Jiang*, Yuke Li, Xiujuan Fu, Yue Wu, Rujing Wang, Canquan Mao, Sanjun Shi*. Interplay between G protein-coupled receptors and nanotechnology. Acta Biomater. 2023; 169: 1-18 (IF= 9.7)

• Yuhong Jiang, Junxian Lim, Kai-Chen Wu, Weijun Xu, Jacky Y. Suen, David P. Fairlie*. PAR2 induces ovarian cancer cell motility by merging three signalling pathways to transactivate EGFR. Br. J. Pharmacol. 2021; 178: 913-932 (IF= 8.74)